Suchen
Kenvue Inc
KVUEZur Watchlist hinzufügen
19.710USD
+0.670+3.52%
Trading geöffnet 10/22, 14:09（ET）
37.84BMarktkapitalisierung
23.31KGV TTM
Über Kenvue Inc Unternehmen
Kenvue Inc. is a consumer health company. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
Kenvue Inc Profil
BörsenkürzelKVUE
Name des UnternehmensKenvue Inc
IPO-datumMay 04, 2023
CEOPerry (Kirk L)
Anzahl der mitarbeiter22000
WertpapierartOrdinary Share
GeschäftsjahresendeMay 04
Addresse1 Kenvue Way
StadtSUMMIT
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl07901
Telefon19088741200
Websitehttps://www.kenvue.com
BörsenkürzelKVUE
IPO-datumMay 04, 2023
CEOPerry (Kirk L)
Führungskräfte von Kenvue Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Carlton Lawson
Mr. Carlton Lawson
Group President, Europe, Middle East and Africa and Latin America
Group President, Europe, Middle East and Africa and Latin America
148.01K
+24.73%
Ms. Meredith (Meri) Stevens
Ms. Meredith (Meri) Stevens
Chief Operations Officer
Chief Operations Officer
114.18K
+18.01%
Dr. Caroline Tillett
Dr. Caroline Tillett
Chief Scientific Officer
Chief Scientific Officer
77.71K
+20.93%
Mr. Kirk L. Perry
Mr. Kirk L. Perry
Chief Executive Officer, Director
Chief Executive Officer, Director
76.92K
+18.68%
Ms. Luani Alvarado
Ms. Luani Alvarado
Chief People Officer
Chief People Officer
61.41K
+7.07%
Mr. Larry J. Merlo
Mr. Larry J. Merlo
Independent Chairman of the Board
Independent Chairman of the Board
40.94K
--
Mr. Michael E. Sneed
Mr. Michael E. Sneed
Independent Director
Independent Director
37.10K
+70.93%
Ms. Heather Howlett
Ms. Heather Howlett
Interim Chief Financial Officer, Chief Accounting Officer
Interim Chief Financial Officer, Chief Accounting Officer
34.60K
+15.36%
Mr. Jan Meurer
Mr. Jan Meurer
Group President, North America
Group President, North America
33.18K
+13.30%
Ms. Charmaine England
Ms. Charmaine England
Chief Growth Officer
Chief Growth Officer
29.06K
+5.38%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Carlton Lawson
Mr. Carlton Lawson
Group President, Europe, Middle East and Africa and Latin America
Group President, Europe, Middle East and Africa and Latin America
148.01K
+24.73%
Ms. Meredith (Meri) Stevens
Ms. Meredith (Meri) Stevens
Chief Operations Officer
Chief Operations Officer
114.18K
+18.01%
Dr. Caroline Tillett
Dr. Caroline Tillett
Chief Scientific Officer
Chief Scientific Officer
77.71K
+20.93%
Mr. Kirk L. Perry
Mr. Kirk L. Perry
Chief Executive Officer, Director
Chief Executive Officer, Director
76.92K
+18.68%
Ms. Luani Alvarado
Ms. Luani Alvarado
Chief People Officer
Chief People Officer
61.41K
+7.07%
Mr. Larry J. Merlo
Mr. Larry J. Merlo
Independent Chairman of the Board
Independent Chairman of the Board
40.94K
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Kenvue Inc?
Die fünf größten Anteilseigner von Kenvue Inc sind: Mr. Carlton Lawson
Wie viele Institutionen halten Anteile an Kenvue Inc (KVUE)?
Mit Stand vom 2026Q1 halten 2195 Institutionen Anteile an Kenvue Inc, mit einem Gesamtmarktwert von etwa 1.82B, was 94.75% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -195892523.00 gestiegen.
Was ist die größte Einnahmequelle von Kenvue Inc?
Am 2026Q1 erzielte das Geschäft mit Face and Body Care für Kenvue Inc den höchsten Umsatz in Höhe von 711.90M, was 18.00% des Gesamtumsatzes entspricht.